<?xml version="1.0" encoding="UTF-8"?>
<p>Excipients in a paediatric formulation should be chosen appropriately, avoiding any excipients that are potentially toxic or unsuitable for children. Choosing the right excipients in the development of a new paediatric drug is one of the most important aspects, as it requires special safety considerations. In general, the following aspects should be taken into account when selecting an appropriate excipient for a paediatric medicinal product [
 <xref rid="B4-pharmaceutics-13-00387" ref-type="bibr">4</xref>]: 
 <list list-type="bullet">
  <list-item>
   <p>Excipient function in formulation and possible alternatives.</p>
  </list-item>
  <list-item>
   <p>Safety profile of the excipient for children in target age groups, based on a unique and daily exposure.</p>
  </list-item>
  <list-item>
   <p>Expected duration of treatment: short term (a single dose for a few days) or long term (weeks and/or months).</p>
  </list-item>
  <list-item>
   <p>Severity of the condition to be treated and therapeutic alternatives.</p>
  </list-item>
  <list-item>
   <p>Patient acceptability, including palatability.</p>
  </list-item>
  <list-item>
   <p>Allergies and sensitization. Children suffer from sensitization problems more commonly than adults. Applicants should avoid, when possible, excipients with known potential to cause sensitization or allergies.</p>
  </list-item>
 </list>
</p>
